| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Pfizer |
| Recipient: You |
| Company: Medivation/Astellas |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Nektar |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Foundation One Inc |
| Recipient: You |
| Company: Pharmacyclics |
| Recipient: You |
| Company: Foundation Medicine |
| Recipient: You |
| Company: Astellas Pharma |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: lily |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Seattle Genetics |
| Recipient: You |
| Company: EMD Serono |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: AVEO |
| Recipient: You |
| Company: Calithera Biosciences |
| Recipient: You |
| Company: MEI Pharma |
| Recipient: You |
| Company: Genentech |
| Recipient: You |
| Company: Astellas Pharma |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: BN ImmunoTherapeutics |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: TRACON Pharma |
| Recipient: Your Institution |
| Company: Rexahn Pharmaceuticals |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Active Biotech |
| Recipient: Your Institution |
| Company: Bavarian Nordic |
| Recipient: Your Institution |
| Company: Calithera Biosciences |
| Recipient: Your Institution |
| Company: Celldex |
| Recipient: Your Institution |
| Company: Eisai |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Immunomedics |
| Recipient: Your Institution |
| Company: Janssen |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Newlink Genetics |
| Recipient: Your Institution |
| Company: Prometheus |
| Recipient: Your Institution |
| Company: Sanofi |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|